News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aileron Therapeutics to Present at Several Upcoming Peptide Drug Discovery Conferences


5/25/2011 10:28:08 AM

Aileron Therapeutics, Inc., a biopharmaceutical company that has defined a new class of drugs called Stapled Peptides, today announced that Tomi K. Sawyer, Ph.D., chief scientific officer and senior vice president, discovery & innovative technologies at Aileron, will give presentations on the company’s Stapled Peptides platform at several upcoming drug discovery and peptide-focused scientific conferences.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES